tetano
Editor, Senior Moderator
Int J Biol Macromol
. 2022 Jan 17;S0141-8130(22)00109-X.
doi: 10.1016/j.ijbiomac.2022.01.094. Online ahead of print.
Dimerization of SARS-CoV-2 nucleocapsid protein affects sensitivity of ELISA based diagnostics of COVID-19
Wajihul Hasan Khan[SUP] 1 [/SUP], Nida Khan[SUP] 1 [/SUP], Avinash Mishra[SUP] 1 [/SUP], Surbhi Gupta[SUP] 1 [/SUP], Vikrant Bansode[SUP] 1 [/SUP], Deepa Mehta[SUP] 2 [/SUP], Rahul Bhambure[SUP] 2 [/SUP], M Ahmad Ansari[SUP] 3 [/SUP], Shukla Das[SUP] 3 [/SUP], Anurag S Rathore[SUP] 4 [/SUP]
Affiliations
Abstract
Nucleocapsid protein (N protein) is the primary antigen of the virus for development of sensitive diagnostic assays of COVID-19. In this paper, we demonstrate the significant impact of dimerization of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) N-protein on sensitivity of enzyme-linked immunosorbent assay (ELISA) based diagnostics. The expressed purified protein from E. coli is composed of dimeric and monomeric forms, which have been further characterized using biophysical and immunological techniques. Indirect ELISA indicated elevated susceptibility of the dimeric form of the nucleocapsid protein for identification of protein-specific monoclonal antibody as compared to the monomeric form. This finding also confirmed with the modelled structure of monomeric and dimeric nucleocapsid protein via HHPred software and its solvent accessible surface area, which indicates higher stability and antigenicity of the dimeric type as compared to the monomeric form. The sensitivity and specificity of the ELISA at 95% CI are 99.0% (94.5-99.9) and 95.0% (83.0-99.4), respectively, for the highest purified dimeric form of the N protein. As a result, using the highest purified dimeric form will improve the sensitivity of the current nucleocapsid-dependent ELISA for COVID-19 diagnosis, and manufacturers should monitor and maintain the monomer-dimer composition for accurate and robust diagnostics.
Keywords: Nucleocapsid protein; Protein dimerization; SARS-CoV-2.
. 2022 Jan 17;S0141-8130(22)00109-X.
doi: 10.1016/j.ijbiomac.2022.01.094. Online ahead of print.
Dimerization of SARS-CoV-2 nucleocapsid protein affects sensitivity of ELISA based diagnostics of COVID-19
Wajihul Hasan Khan[SUP] 1 [/SUP], Nida Khan[SUP] 1 [/SUP], Avinash Mishra[SUP] 1 [/SUP], Surbhi Gupta[SUP] 1 [/SUP], Vikrant Bansode[SUP] 1 [/SUP], Deepa Mehta[SUP] 2 [/SUP], Rahul Bhambure[SUP] 2 [/SUP], M Ahmad Ansari[SUP] 3 [/SUP], Shukla Das[SUP] 3 [/SUP], Anurag S Rathore[SUP] 4 [/SUP]
Affiliations
- PMID: 35051498
- DOI: 10.1016/j.ijbiomac.2022.01.094
Abstract
Nucleocapsid protein (N protein) is the primary antigen of the virus for development of sensitive diagnostic assays of COVID-19. In this paper, we demonstrate the significant impact of dimerization of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) N-protein on sensitivity of enzyme-linked immunosorbent assay (ELISA) based diagnostics. The expressed purified protein from E. coli is composed of dimeric and monomeric forms, which have been further characterized using biophysical and immunological techniques. Indirect ELISA indicated elevated susceptibility of the dimeric form of the nucleocapsid protein for identification of protein-specific monoclonal antibody as compared to the monomeric form. This finding also confirmed with the modelled structure of monomeric and dimeric nucleocapsid protein via HHPred software and its solvent accessible surface area, which indicates higher stability and antigenicity of the dimeric type as compared to the monomeric form. The sensitivity and specificity of the ELISA at 95% CI are 99.0% (94.5-99.9) and 95.0% (83.0-99.4), respectively, for the highest purified dimeric form of the N protein. As a result, using the highest purified dimeric form will improve the sensitivity of the current nucleocapsid-dependent ELISA for COVID-19 diagnosis, and manufacturers should monitor and maintain the monomer-dimer composition for accurate and robust diagnostics.
Keywords: Nucleocapsid protein; Protein dimerization; SARS-CoV-2.